HLAG Antikörper (PE)
Kurzübersicht für HLAG Antikörper (PE) (ABIN569698)
Target
Alle HLAG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- The antibody reacts with native form of Human HLA-G1 on the cell surface as well as with soluble HLA-G5 isoform in its beta2-microglobulin associated form. The clone MEM-G/9 is standard reagent thoroughly validated during 3rd International Conference on HLA-G (Paris, 2003).
-
Keine Kreuzreaktivität
- Maus
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Immunogen
- Recombinant human HLA-G refolded with beta2-microglobulin and peptide
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.1 mg/mL
-
Buffer
- PBS containing 15 mM Sodium Azide and 0.2 % (w/v) high-grade protease free BSA as a stabilizing agent.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
-
-
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Andere Bezeichnung
- HLA Class I alpha G / HLA-G
-
Hintergrund
- HLA-G belongs to the MHC Class I molecules (MHC Class Ib, nonclassical) and it is expressed on the surface of trophoblast cells.Synonyms: HLA class I histocompatibility antigen, HLA-6.0, HLAG, MHC class I antigen G
-
Gen-ID
- 3135
-
NCBI Accession
- NP_002118
-
UniProt
- P17693
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-